Bispecific Antibody
Creative Biolabs is a specialized manufacturer of bispecific antibodies based on our advanced technology and years of experience. We are available to supply all kinds of bispecific antibodies that can be applicated in various research uses.
Bispecific antibodies are now being served as effective therapeutic agents in cancer immunotherapy. Certain recombinant strategies have been developed to synthesize bispecific antibodies, which include single chain variable fragment (scFv)-derived formats such as tandem diabodies, diabodies, BiIEs (bispecific immune cell engagers), and, as well as immunoglobulin G(IgG)-based formats such as two-in-one antibodies.
We offer a number of advanced strategies (recombinant DNA technology, phage display technology etc.) to synthesize the most comprehensive bispecific antibodies above-mentioned with high purity and affinity.
-
- Targets: CD19 & CD47
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: NG2 & CD28
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: Ang2 & VEGFA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: VEGF & VEGF-B
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD33 & FcγRIII
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: EPCAM & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: VEGFR2 & VEGFR3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: Melanoma-associated proteoglycan & CD28
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: PDGFR2 & VEGFR2
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: EGFR & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: PLAP & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FcγRIII & CD30
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: EGFR & IGFR
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FcγRIIB & LPA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FcγRI & LPA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: TCR(Vβ 8 ) & M2
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD28 & melanoma-associated proteoglycan
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: S protein & pre S2 protein
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: Thyroglobulin & TPO
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FOLR1 & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FN1 & HSG
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: TROP-2 & HSG
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CEA & Ad fiber knob
- Type: Tandem Diabody
- Application: FuncS, Gene delivery in gene therapy
Compare
-
- Targets: CD40 & Ad fiber knob
- Type: Tandem Diabody
- Application: FuncS, Gene delivery in gene therapy
Compare
-
- Targets: C5 & HRPO
- Type: Tandem Diabody
- Application: FuncS, Immunoassay
Compare
-
- Targets: EGFR & ZnO
- Type: Tandem Diabody
- Application: FuncS, Immunoassay
Compare
-
- Targets: phenyloxazolone(phOx) & hen egg lysosome(HEL)
- Type: Tandem Diabody
- Application: FuncS, Immunoassay
Compare
-
- Targets: FcγRIII & CD33 & CD19
- Type: Triplebody
- Application: FC
Compare
-
- Targets: CD19 & CD3
- Type: Tandem Diabody
Compare
-
- Targets: CD30 & CD16A
- Type: Tandem Diabody
Compare
-
- Targets: Ang2 & VEGFA
- Type: CrossMab
Compare
-
- Targets: CEA & HSG
- Type: CrossMab
Compare
-
- Targets: EGFR & Fcgr1
- Type: CrossMab
Compare
-
- Targets: CD74 & CD22
- Type: BsFab
Compare
-
- Targets: CD19 & CD64
- Type: BsFab
Compare
-
- Targets: CD22 & CD79b
- Type: Tandem Diabody
- Application: FC
Compare
-
- Targets: CD33 & CD3
- Type: Tandem Diabody
- Application: FC
Compare
-
- Targets: CD33 & CD3
- Type: Tandem Diabody
- Application: FC
Compare
-
- Targets: CD38 & CD3
- Type: Triplebody
- Application: SPR
Compare
-
- Targets: EGFRvIII & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: GPC3 & CD3
- Type: DAF
- Application: FC, ELISA
Compare
-
- Targets: MCSP & CD3
- Type: CrossMab
- Application: FC, ELISA
Compare
-
- Targets: IL23R & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: IL5R & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: PROM1 & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: ROR1 & CD3
- Type: Triplebody
- Application: FC
Compare
-
- Targets: ROR1 & CD3
- Type: CrossMab
- Application: FC
Compare
-
- Targets: ROR1 & CD3
- Type: Fab2
- Application: FC
Compare
-
- Targets: CD300A & IgE
- Type: Fab2
- Application: FC
Compare
-
- Targets: CD300A & IgE
- Type: Fab2
- Application: FC
Compare
-
- Targets: CD45 & CD79
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: PAC1 receptor & CGRP receptor
- Type: CrossMab
- Application: ELISA
Compare
-
- Targets: CD30 & ErbB2
- Type: CrossMab
- Application: ELISA
Compare
-
- Targets: MET & EGFR
- Type: Triplebody
- Application: WB, ICC
Compare
-
- Targets: MET & EGFR
- Type: Triplebody
- Application: FC
Compare
-
- Targets: MET & EpCAM
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: MET & ErbB-2
- Type: Triplebody
- Application: WB, Confocal
Compare
-
- Targets: MET & ErbB-3
- Type: Triplebody
- Application: Biacore assay, Cell proliferation assay
Compare
-
- Targets: MET & VEGF
- Type: IgG-IgG
- Application: ELISA
Compare
-
- Targets: MET & VEGFR-2
- Type: scFv2-Fc
- Application: FC
Compare
-
- Targets: CTLA4 & PD-1
- Type: Triplebody
- Application: FC
Compare
-
- Targets: D-DT & MIF
- Type: Fab2
- Application: ELISA
Compare
-
- Targets: DLL4 & VEGF
- Type: Bi-sdAb
- Application: ELISA
Compare
-
- Targets: EGFR & ErbB-2
- Type: IgG-IgG
- Application: ELISA
Compare
-
- Targets: HER2 & VEGF
- Type: F(ab')2
- Application: FC
Compare
-
- Targets: EGFR & ErbB-3
- Type: Fab2
- Application: FC, ADCC Reporter Bioassay
Compare
-
- Targets: HER3 & ErbB-2
- Type: Bi-sdAb
- Application: PET-CT imaging
Compare
-
- Targets: EGFR & IGF-1R
- Type: Triplebody
- Application: FC, ELISA
Compare
-
- Species Reactivity: EBV
- Epitope: HPVGDADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV
- Epitope: HPVGDADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV
- Epitope: HPVGDADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV
- Epitope: HPVGDADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.